PL2215047T3 - Sposób leczenia niedoborów witaminy b12 - Google Patents

Sposób leczenia niedoborów witaminy b12

Info

Publication number
PL2215047T3
PL2215047T3 PL08844673T PL08844673T PL2215047T3 PL 2215047 T3 PL2215047 T3 PL 2215047T3 PL 08844673 T PL08844673 T PL 08844673T PL 08844673 T PL08844673 T PL 08844673T PL 2215047 T3 PL2215047 T3 PL 2215047T3
Authority
PL
Poland
Prior art keywords
deficiency
treating vitamin
vitamin
treating
Prior art date
Application number
PL08844673T
Other languages
English (en)
Inventor
Cristina Castelli
Laura Kragie
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40591491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2215047(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of PL2215047T3 publication Critical patent/PL2215047T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PL08844673T 2007-11-02 2008-10-31 Sposób leczenia niedoborów witaminy b12 PL2215047T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US98489807P 2007-11-02 2007-11-02
US2010808P 2008-01-09 2008-01-09
US8356608P 2008-07-25 2008-07-25
PCT/US2008/082064 WO2009059188A1 (en) 2007-11-02 2008-10-31 Method of treating vitamin b12 deficiency
EP08844673.7A EP2215047B1 (en) 2007-11-02 2008-10-31 Method of treating vitamin b12 deficiency

Publications (1)

Publication Number Publication Date
PL2215047T3 true PL2215047T3 (pl) 2014-05-30

Family

ID=40591491

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08844673T PL2215047T3 (pl) 2007-11-02 2008-10-31 Sposób leczenia niedoborów witaminy b12

Country Status (19)

Country Link
US (3) US8022048B2 (pl)
EP (1) EP2215047B1 (pl)
JP (1) JP5555634B2 (pl)
KR (1) KR101344369B1 (pl)
CN (1) CN101952241B (pl)
AU (1) AU2008318423B2 (pl)
BR (1) BRPI0817396C8 (pl)
CA (1) CA2704780C (pl)
CL (1) CL2010000434A1 (pl)
CO (1) CO6280475A2 (pl)
DK (1) DK2215047T3 (pl)
ES (1) ES2443817T3 (pl)
HK (1) HK1146480A1 (pl)
MX (1) MX2010004716A (pl)
NZ (1) NZ585080A (pl)
PL (1) PL2215047T3 (pl)
PT (1) PT2215047E (pl)
RU (1) RU2469728C2 (pl)
WO (1) WO2009059188A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011017346A2 (en) * 2009-08-03 2011-02-10 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
TWI590829B (zh) * 2010-02-24 2017-07-11 艾米斯菲爾科技股份有限公司 口服ｂ１２的療法
BR112013014942B1 (pt) 2010-12-16 2020-01-28 Novo Nordisk As composições sólidas para administração, e seus usos
WO2012140117A1 (en) 2011-04-12 2012-10-18 Novo Nordisk A/S Double-acylated glp-1 derivatives
US8805208B2 (en) * 2012-02-03 2014-08-12 Tyco Electronics Subsea Communications Llc System and method for polarization de-multiplexing in a coherent optical receiver
HUE039406T2 (hu) 2012-03-22 2018-12-28 Novo Nordisk As GLP-1 peptid készítményei és azok elõállítása
HUE042757T2 (hu) 2012-03-22 2019-07-29 Novo Nordisk As Szállító szert tartalmazó készítmények és elõállításuk
CN111494324B (zh) 2012-03-22 2023-05-16 诺和诺德股份有限公司 包含递送剂的组合物及其制备
CN104487056A (zh) 2012-06-20 2015-04-01 诺和诺德A/S（股份有限公司） 包含肽和递送剂的片剂制剂
US10098848B2 (en) 2013-04-11 2018-10-16 Richard Louis Price Inositol-containing comestible units and methods of treatment using the same
US9603812B2 (en) 2013-04-11 2017-03-28 Richard Louis Price Treatment of autistic spectrum disorder
US20170348417A1 (en) 2013-04-11 2017-12-07 Richard Louis Price Treatment of attention deficit disorders and associated symptoms
US9211284B2 (en) 2013-04-11 2015-12-15 Richard Louis Price Diagnosis and treatment of P.R.I.C.E. syndrome
US20140309270A1 (en) 2013-04-11 2014-10-16 Richard Louis Price Diagnosis and treatment of a form of autistic spectrum disorder
MX2018012913A (es) 2016-04-22 2019-01-30 Receptor Life Sciences Inc Compuestos medicinales y suplementos nutricionales de base vegetal de rapida accion.
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
AR113749A1 (es) * 2017-10-05 2020-06-10 Receptor Holdings Inc Formulaciones cannabinoides sintéticas y a base de plantas de inicio rápido y acción prolongada
JP2020536858A (ja) * 2017-10-05 2020-12-17 レセプター・ホールディングス・インコーポレイテッド 改善されたバイオアベイラビリティーを有するハーブ組成物
HUE063787T2 (hu) 2018-02-02 2024-01-28 Novo Nordisk As Egy GLP-1 agonistát, egy N-(8-(2-hidroxibenzoil)amino) kaprilsav sót és egy síkosítóanyagot tartalmazó szilárd készítmények

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665379A (en) 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US6274564B1 (en) * 1996-09-18 2001-08-14 William J. Sarill Compositions of cobalamin and related corrinoids, and uses thereof
US5773647A (en) 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
MXPA01006297A (es) * 1998-12-28 2002-06-04 Biogentec Inc Tratamiento con cianocobalamina (vitamina b12) para enfermedades alergicas.
EP1535625B1 (en) 1999-04-05 2014-01-08 Novartis AG Composition containing n-(5-chlorosalicyloyl)-8-aminocaprylic acid and salmon calcitonin
IL145546A0 (en) 1999-04-05 2002-06-30 Emisphere Tech Inc Disodium salts, monohydrates, and ethanol solvates for delivering active agents
WO2001070219A1 (en) 2000-03-21 2001-09-27 Emisphere Technologies, Inc. Method of preparing alkylated salicylamides via a dicarboxylate intermediate
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
BRPI0209748B1 (pt) 2001-06-01 2015-11-24 Novartis Ag composição farmacêutica para administração oral compreendendo hormonio paratireoide(pth), e seu uso
HUP0401441A3 (en) 2001-08-17 2012-09-28 Novartis Ag 5-cnac as oral delivery agent for parathyroid hormone fragments
US20050054557A1 (en) 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin
TW200403052A (en) 2002-07-17 2004-03-01 Novartis Ag Use of organic compounds
PE20040724A1 (es) 2002-08-01 2004-12-06 Novartis Ag Composicion para la administracion oral de calcitonina
EP1545477A4 (en) * 2002-09-13 2006-11-22 Cydex Inc CAPSULES CONTAINING AQUEOUS FILLING COMPOSITIONS STABILIZED WITH DERIVED CYCLODEXTRIN
CN100579955C (zh) 2003-04-04 2010-01-13 帝斯曼知识产权资产管理有限公司 N-烷氧基草酰丙氨酸酯的制备方法
US6938439B2 (en) 2003-05-22 2005-09-06 Cool Clean Technologies, Inc. System for use of land fills and recyclable materials
JP3924616B2 (ja) 2003-06-30 2007-06-06 独立行政法人物質・材料研究機構 微小サイズの温度感知素子を用いる温度計測方法
WO2005002549A1 (en) 2003-07-04 2005-01-13 Nycomed Danmark Aps Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
PT1651248E (pt) 2003-07-11 2009-11-10 Novartis Ag Composições farmacêuticas para dose oral compreendendo um agente de administração na forma micronizada
AU2004262906B2 (en) 2003-07-23 2008-04-03 Nordic Bioscience A/S Use of calcitonin in osteoarthritis
AU2005240213B8 (en) * 2004-05-06 2011-10-20 Emisphere Technologies, Inc. Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
MX2007001348A (es) 2004-08-02 2008-03-11 Bebaas Inc Composiciones de vitamina b12.
US20060078623A1 (en) 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US20060116334A1 (en) * 2004-12-01 2006-06-01 Curt Hendrix Folate based composition for treatment of the cardiovascular system
GB0427603D0 (en) 2004-12-16 2005-01-19 Novartis Ag Organic compounds
GB0427600D0 (en) 2004-12-16 2005-01-19 Novartis Ag Organic compounds
ZA200803283B (en) 2005-11-04 2009-11-25 Genta Inc Pharmaceutical gallium compositions and methods

Also Published As

Publication number Publication date
US8022048B2 (en) 2011-09-20
KR20100126263A (ko) 2010-12-01
WO2009059188A1 (en) 2009-05-07
AU2008318423B2 (en) 2013-12-05
BRPI0817396B1 (pt) 2019-04-24
BRPI0817396A2 (pt) 2015-04-07
ES2443817T3 (es) 2014-02-20
KR101344369B1 (ko) 2013-12-24
PT2215047E (pt) 2014-01-20
US8288360B2 (en) 2012-10-16
US20130040910A1 (en) 2013-02-14
CA2704780C (en) 2014-06-10
NZ585080A (en) 2012-05-25
DK2215047T3 (da) 2014-02-03
MX2010004716A (es) 2010-12-17
BRPI0817396C1 (pt) 2020-11-17
EP2215047B1 (en) 2013-11-20
CN101952241B (zh) 2014-06-11
CL2010000434A1 (es) 2011-01-28
JP5555634B2 (ja) 2014-07-23
EP2215047A1 (en) 2010-08-11
BRPI0817396C8 (pt) 2021-05-25
CO6280475A2 (es) 2011-05-20
CA2704780A1 (en) 2009-05-07
RU2469728C2 (ru) 2012-12-20
US20100016255A1 (en) 2010-01-21
US8557792B2 (en) 2013-10-15
EP2215047A4 (en) 2010-11-10
CN101952241A (zh) 2011-01-19
BRPI0817396B8 (pt) 2020-02-04
JP2011502997A (ja) 2011-01-27
AU2008318423A1 (en) 2009-05-07
HK1146480A1 (en) 2011-06-10
US20110293589A1 (en) 2011-12-01
RU2010118423A (ru) 2011-12-10

Similar Documents

Publication Publication Date Title
HK1146480A1 (en) Method of treating vitamin b12 deficiency b12
PL2148684T3 (pl) Sposób leczenia niedoboru i deficytu witaminy D
ZA201707693B (en) Vitamin d3 and analogs thereof for treating alopecia
IL212348A0 (en) Treatment method
IL227641A0 (en) Methods for treating arthritis
EP2313103A4 (en) PROCESS FOR TREATING A BLÉPHARITE
EP2174912A4 (en) PROCESS FOR MACHINING A COPPER ARSEN COMPOUND
EP2148685A4 (en) METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
PL2301893T3 (pl) Sposób oczyszczania ścieku
HK1138198A1 (en) Stabilization of vitamin b12
EP2174914A4 (en) PROCESS FOR TREATING DIARSENIC TRIOXIDE
EP2144504A4 (en) METHOD FOR COMBATING BRAIN CANCER
IL200769A (en) A method for processing potash
EP2350641A4 (en) Methods of Treatment
IL238394A0 (en) Cancer treatment method
EP2164515A4 (en) PROCESS FOR TREATING ATOPIC ECZEMA
PT2393758E (pt) Processo de tratamento de águas residuais
GB0718684D0 (en) Treatment method
EP2367544A4 (en) METHOD FOR TREATING AGGRESSION
PT2509599E (pt) Processo para o tratamento de cancro pancreático
EP2162021A4 (en) METHOD FOR TREATING FOODSTUFFS
EP2203432A4 (en) PROCESSING METHOD
GB0723972D0 (en) Use of vitamin B12
GB0717337D0 (en) Method of treatment
GB0711228D0 (en) Treatment method